Bríd O’Flaherty
Bríd O’Flaherty is a barrister appointed as the chairwoman of the inquiry into the historical licensing and use of the anti-epileptic drug sodium valproate in Ireland, a role that involves leading investigations into the drug's impact on women of childbearing age and the potential risks to their children.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Ireland:
In June 2024, barrister Bríd O’Flaherty was appointed as chairwoman of the inquiry.
7